Toe amputations with SGLT-2 inhibitors: data from randomized clinical trials

被引：0
|
作者：
Matteo Monami
Stefania Zannoni
Besmir Nreu
Edoardo Mannucci
机构：
[1] Careggi Teaching Hospital,Diabetology
[2] Careggi Teaching Hospital,Geriatric Medicine
来源：
Acta Diabetologica | 2017年 / 54卷
关键词：
Intervention study; Hypoglycemic agents; Diabetic ketoacidosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：411 / 413
页数：2
相关论文
共 50 条
  • [1] Toe amputations with SGLT-2 inhibitors: data from randomized clinical trials
    Monami, Matteo
    Zannoni, Stefania
    Nreu, Besmir
    Mannucci, Edoardo
    ACTA DIABETOLOGICA, 2017, 54 (04) : 411 - 413
  • [2] SAFETY EVALUATION OF SGLT-2 INHIBITORS: A PHARMACOVIGILANCE ANALYSIS USING REALWORLD DATA AND RANDOMIZED CLINICAL TRIALS
    Bhanushali, Karan B.
    Asnani, Heena
    Nair, Ambica Vivek
    Ganatra, Sarju
    Dani, Sourbha S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2043 - 2043
  • [3] Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials
    Dicembrini, Ilaria
    Tomberli, Benedetta
    Nreu, Besmir
    Baldereschi, Giorgio Iacopo
    Fanelli, Fabrizio
    Mannucci, Edoardo
    Monami, Matteo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 153 : 138 - 144
  • [4] Clinical pharmacology of SGLT-2 inhibitors in heart failure
    Velliou, Maria
    Polyzogopoulou, Effie
    Ventoulis, Ioannis
    Parissis, John
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (02) : 149 - 160
  • [5] SGLT-2 inhibitors and dementia
    Tu, Sung-Yun
    Shao, Shih-Chieh
    Loh, Ching-Hui
    Huang, Huei-Kai
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 386
  • [6] SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials
    Robert Puckrin
    Marie-Philippe Saltiel
    Pauline Reynier
    Laurent Azoulay
    Oriana H. Y. Yu
    Kristian B. Filion
    Acta Diabetologica, 2018, 55 : 503 - 514
  • [7] SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials
    Puckrin, Robert
    Saltiel, Marie-Philippe
    Reynier, Pauline
    Azoulay, Laurent
    Yu, Oriana H. Y.
    Filion, Kristian B.
    ACTA DIABETOLOGICA, 2018, 55 (05) : 503 - 514
  • [8] Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials
    Mannucci, Edoardo
    Dicembrini, Ilaria
    Nreu, Besmir
    Monami, Matteo
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2020, 30 (01) : 71 - 76
  • [9] Amputation Risk in Type II Diabetes Mellitus Patients Treated with SGLT-2 Inhibitors: A Systematic Literature Review of Randomized Clinical Trials
    Hoda, Farazul
    Jamali, Mohammad Chand
    Arshad, Mawrah
    Habib, Mohammad Anwar
    Akhtar, Mohd
    Najmi, Abul Kalam
    DRUG RESEARCH, 2024, 74 (09) : 425 - 432
  • [10] SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2
    Zhou, Ying
    Fan, Jinjin
    Zheng, Chenfei
    Yin, Peiran
    Wu, Haishan
    Li, Xiaoyan
    Luo, Ning
    Yu, Xueqing
    Chen, Chaosheng
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 : 1327 - 1338
12345